RGNXREGENXBIO Inc.

CSNasdaq (XNAS)·USD

Identity

Security key: 20946
Ticker: RGNX
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2015-09-17
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: RGNX

Detail

Enriched 2026-08-14 20:47

Market cap: $720,203,924.72
Shares outstanding (class): 66,013,192
Shares outstanding (weighted): 66,013,192
SIC: 2836 BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees: 371
Location: ROCKVILLE, MD
Homepage: https://www.regenxbio.com
Description: Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.

Market cap and share counts drift.

Funds holding this security

101 funds · 104 positions · $82.12M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$11.97M	0.00%	1,428,039 NS	FIGI
State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST	XBI	$11.43M	0.15%	1,363,810 NS	FIGI
JPMorgan Small Cap Growth Fund JPMorgan Trust II	—	$11.10M	0.51%	1,324,789 NS	FIGI
iShares Russell 2000 ETF iShares Trust	IWM	$9.69M	0.01%	1,156,758 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$4.45M	0.01%	531,593 NS	FIGI
JPMorgan Small Cap Blend Fund JPMorgan Trust I	—	$3.58M	0.25%	427,691 NS	FIGI
iShares Russell 2000 Value ETF iShares Trust	IWN	$3.35M	0.03%	399,985 NS	FIGI
VANGUARD STRATEGIC SMALL-CAP EQUITY FUND VANGUARD HORIZON FUNDS	—	$3.17M	0.13%	377,777 NS	FIGI
iShares Biotechnology ETF iShares Trust	IBB	$2.78M	0.03%	331,423 NS	FIGI
Fidelity Enhanced Small Cap ETF Fidelity Covington Trust	FESM	$2.43M	0.06%	290,327 NS	FIGI
State Street(R) SPDR(R) S&P Kensho New Economie… SPDR SERIES TRUST	KOMP	$2.23M	0.09%	265,629 NS	FIGI
VANGUARD MARKET NEUTRAL FUND VANGUARD MONTGOMERY FUNDS	—	$2.03M	0.47%	241,853 NS	FIGI
JPMorgan Small Cap Value Fund JPMorgan Trust II	—	$1.49M	0.13%	178,244 NS	FIGI
Nomura Healthcare Fund Delaware Group Equity Funds IV	—	$1.25M	0.19%	149,000 NS	FIGI
JPMorgan U.S. Small Company Fund JPMorgan Trust I	—	$1.00M	0.11%	119,683 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERRGNX
FIGI_COMPOSITEBBG007Z9V591
FIGI_SHARE_CLASSBBG007Z9V5C7
CIK0001590877
ISINUS75901B1070
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Biotechnology
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: REGENXBIO is a clinical-stage biotechnology company developing gene therapies, fitting the biotechnology industry under healthcare.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.